What are the proper dosing directions for oral nystatin suspension?

Oral Nystatin Dosing Directions

For mild oropharyngeal candidiasis (oral thrush), administer nystatin suspension (100,000 U/mL) at 4-6 mL four times daily for 7-14 days, OR use nystatin pastilles (200,000 U each) 1-2 pastilles four times daily for 7-14 days 1.

Administration Instructions

Suspension Formulation

• Dose: 4-6 mL of 100,000 U/mL suspension
• Frequency: Four times daily
• Duration: 7-14 days
• Critical instruction: Shake well before using 2
• Technique: Patient should swish the suspension in mouth as long as possible before swallowing to maximize contact time with oral mucosa

Pastille Formulation

• Dose: 1-2 pastilles (200,000 U each)
• Frequency: Four times daily
• Duration: 7-14 days
• Technique: Allow pastille to dissolve slowly in mouth; do not chew or swallow whole

Key Clinical Considerations

When Nystatin is Appropriate

Nystatin is recommended as an alternative agent for mild oropharyngeal candidiasis only 1. The 2016 IDSA guidelines give it a strong recommendation with moderate-quality evidence, but position it as second-line to clotrimazole troches or miconazole for mild disease.

Important Limitations

• Nystatin is NOT appropriate for moderate-to-severe disease - these patients require oral fluconazole 100-200 mg daily 1
• Nystatin suspension has inferior efficacy compared to pastilles due to rapid elimination from the oral cavity 3. Pastilles maintain antifungal activity for at least 5 hours versus rapid elimination with suspension
• Research shows nystatin suspension is not superior to fluconazole in infants, children, or HIV/AIDS patients 4

Optimizing Efficacy

• Pastilles alone or pastilles + suspension combined are more effective than suspension alone 4, 3
• Higher pastille doses (400,000 U) achieve better mycological cure rates than 200,000 U 4
• Extended treatment to 4 weeks may improve outcomes in refractory cases 4
• For denture-related candidiasis, denture disinfection must accompany antifungal therapy 1

Common Pitfalls to Avoid

1. Using nystatin for moderate-severe disease: These patients need systemic azoles, not topical therapy
2. Inadequate contact time: Suspension must be swished thoroughly before swallowing; pastilles must dissolve slowly
3. Prescribing suspension when pastilles would be more effective: If patient can tolerate pastilles, prefer this formulation
4. Stopping treatment too early: Complete the full 7-14 day course even if symptoms resolve
5. Poor taste and GI upset are the most common adverse effects 4 - counsel patients this is expected

Available Formulations

• Suspension: 100,000 U/mL in 60 mL, 237 mL, or 480 mL bottles 2
• Unit dose cups: 5 mL cups containing 500,000 units total 2
• Contains 0.5-1% alcohol 2
• Store at room temperature 20-25°C; avoid freezing 2